Over the past 30 years, the number of drugs targeting neglected
diseases is ten if we consider the most neglected diseases, 18 if we add
malaria, and 21 if we add tuberculosis. These totals still represent only
around 1% of all new drugs (1,556) launched during this period — a situation that is essentially unchanged from five years ago.